Individuals can vary drastically in their response to the same treatment, and this heterogeneity has driven the push for more personalized medicine. Accurate and interpretable methods to identify subgroups that respond to the treatment differently from the population average are necessary to achieving this goal. The Virtual Twins (VT) method by Foster et al. \cite{Foster} is a highly cited and implemented method for subgroup identification because of its intuitive framework. However, since its initial publication, many researchers still rely heavily on the authors' initial modeling suggestions without examining newer and more powerful alternatives. This leaves much of the potential of the method untapped. We comprehensively evaluate the performance of VT with different combinations of methods in each of its component steps, under a collection of linear and nonlinear problem settings. Our simulations show that the method choice for step 1 of VT is highly influential in the overall accuracy of the method, and Superlearner is a promising choice. We illustrate our findings by using VT to identify subgroups with heterogeneous treatment effects in a randomized, double-blind nicotine reduction trial.
翻译:个人对同一治疗的反应可能差别很大,这种差异性促使人们推崇更加个性化的药物。为了实现这一目标,必须采用精确和可解释的方法来识别对治疗反应不同于人口平均数的分组。Foster 等人的虚拟双胞胎(VT)方法因其直观框架而是一个引人高度引用和实施的分组识别方法。然而,自最初出版以来,许多研究人员仍然大量依赖作者的初步建模建议,而不研究较新的和较强大的替代方法。这留下了未开发方法的大部分潜力。我们在收集线性和非线性问题设置的情况下,全面评价其每个组成部分步骤的不同方法组合。我们的模拟表明,对VT第1步的方法选择对于方法的总体准确性具有很大影响,超级激光器是一个很有希望的选择。我们通过使用VT在随机、双线性尼可丁酸减少试验中确定具有不同治疗效果的分组来说明我们的调查结果。